Symbols

TRIB

Trinity Biotech·NASDAQ

--(--)

7.14 / 10

Outperform

Analyst coverage is absent, but fund‑flow sentiment is strong at 7.14/10 (good). Inflow ratios are modest (~0.4) across all investor sizes, though trends are negative. Liquidity remains healthy, yet caution is advised.

Fund Flow Rating

Is money flowing into or out of TRIB?

TRIB holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.14/10 (Outperform).